Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,451 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of mild exercise on glycemic and bodyweight control in Japanese type 2 diabetes patients: A retrospective analysis.
Nakanishi S, Iwamoto M, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Okauchi S, Kinoshita T, Sanada J, Fushimi Y, Nishioka M, Mizoguchi A, Kameyama M, Mune T, Kaku K, Kaneto H. Nakanishi S, et al. Among authors: iwamoto m. J Diabetes Investig. 2019 Jan;10(1):104-107. doi: 10.1111/jdi.12832. Epub 2018 Mar 30. J Diabetes Investig. 2019. PMID: 29526038 Free PMC article.
Mental distress and health-related quality of life among type 1 and type 2 diabetes patients using self-monitoring of blood glucose: A cross-sectional questionnaire study in Japan.
Tanaka N, Yabe D, Murotani K, Ueno S, Kuwata H, Hamamoto Y, Kurose T, Takahashi N, Akashi T, Matsuoka T, Osonoi T, Minami M, Shimono D, Seino Y; Positive SMBG Study Group Investigators. Tanaka N, et al. J Diabetes Investig. 2018 Sep;9(5):1203-1211. doi: 10.1111/jdi.12827. Epub 2018 Apr 1. J Diabetes Investig. 2018. PMID: 29493881 Free PMC article.
Efficacy and Safety of Switching from Insulin Glargine 100 U/mL to the Same Dose of Glargine 300 U/mL in Japanese Type 1 and 2 Diabetes Patients: A Retrospective Analysis.
Nakanishi S, Iwamoto M, Kamei S, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Kimura T, Kinoshita T, Irie S, Sanada J, Fushimi Y, Nishioka M, Mizoguchi A, Kameyama M, Mune T, Kaku K, Kaneto H. Nakanishi S, et al. Among authors: iwamoto m. Intern Med. 2018;57(10):1381-1389. doi: 10.2169/internalmedicine.9334-17. Epub 2018 May 15. Intern Med. 2018. PMID: 29760318 Free PMC article.
Applications of physical performance measures to routine diabetes care for frailty prevention concept: fundamental data with grip strength, gait speed, timed chair stand speed, standing balance, and knee extension strength.
Yokoyama H, Shiraiwa T, Takahara M, Iwamoto M, Kuribayashi N, Nomura T, Yamada M, Sone H, Araki SI. Yokoyama H, et al. Among authors: iwamoto m. BMJ Open Diabetes Res Care. 2020 Sep;8(1):e001562. doi: 10.1136/bmjdrc-2020-001562. BMJ Open Diabetes Res Care. 2020. PMID: 32948539 Free PMC article.
Clinical course of different long-acting insulin therapies-glargine U100, U300, degludec, and insulin degludec/insulin aspart-among Japanese patients with type 2 diabetes: a multicenter retrospective observational study (JDDM65 study).
Iwamoto M, Nakanishi S, Iwamoto H, Kaneto H, Maegawa H; Japan Diabetes Clinical Data Management Study Group (JDDM study group). Iwamoto M, et al. Among authors: iwamoto h. Endocr J. 2022 Jul 28;69(7):763-771. doi: 10.1507/endocrj.EJ21-0647. Epub 2022 Jan 26. Endocr J. 2022. PMID: 35082188 Free article.
Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66).
Yokoyama H, Araki SI, Yamazaki K, Kawai K, Shirabe SI, Oishi M, Kanatsuka A, Yagi N, Kabata D, Shintani A, Maegawa H; JDDM study group. Yokoyama H, et al. BMJ Open Diabetes Res Care. 2022 May;10(3):e002727. doi: 10.1136/bmjdrc-2021-002727. BMJ Open Diabetes Res Care. 2022. PMID: 35504696 Free PMC article.
The renoprotective effect of once-weekly GLP-1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67).
Tsuchida KI, Taneda S, Yokota I, Okada K, Kurihara Y, Yokoyama H, Iwamoto M, Yamazaki K, Ishigaki Y, Manda N, Maegawa H; Japan Diabetes Clinical Data Management Study Group (JDDM study group). Tsuchida KI, et al. Among authors: iwamoto m. J Diabetes Investig. 2022 Nov;13(11):1834-1841. doi: 10.1111/jdi.13877. Epub 2022 Jul 5. J Diabetes Investig. 2022. PMID: 35735780 Free PMC article.
1,451 results